Supporting immune and mitochondrial health in older adults with targeted nutrition
Official title: Maintaining Immune and Mitochondrial Functions in Old Adults With SAfe Nutrition: the MIMOSA Study.
Run by Centre Hospitalier Universitaire Vaudois · NCT05324475 · Data updated 2026-11-12
This trial will test whether a personalized supplement containing branched-chain amino acids, micronutrients, and omega-3s helps older adults with malnutrition and sarcopenia improve muscle, immune, and mitochondrial function.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 75 Years and up |
| Sex | All |
| Enrollment | 240 (estimated) |
| Sponsor | Centre Hospitalier Universitaire Vaudois Academic / other |
| Locations | 1 site (Lausanne, Switzerland) |
| Status | Recruiting |
| Started | April 1, 2025 |
| Main results expected | December 30, 2027 |
| Study ends | March 30, 2028 |
| Registry record updated | May 31, 2025 |
| Trial ID | NCT05324475 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 75 or older entering rehabilitation with malnutrition (MNA-SF <11) who can consent and take oral supplements and attend follow-up at the study site.
✕Probably not a fit
Patients with active malignancy, life expectancy under two months, severe heart failure (NYHA IV), advanced renal failure (CrCl <40 ml/min), decompensated cirrhosis, enteral/parenteral feeding, severe dysphagia, or severe cognitive impairment are unlikely to benefit or are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants aged 75 and older entering a rehabilitation program with malnutrition (MNA-SF <11) will receive standard nutritional care plus a daily oral supplement for 6 weeks. For blinding, all participants take one sachet and two capsules daily; the active group receives BCAA, a micronutrient blend, and omega‑3 capsules, while the placebo group receives maltodextrin and coconut oil. Muscle mass (BIA), handgrip strength, and SPPB performance will be measured, and biological samples will be collected to examine mitochondrial function, oxidative stress, and immune markers. The intervention is intended to restore protein and micronutrient deficits and test whether that improves clinical and biological outcomes linked to inflammaging and sarcopenia.
Why it matters
Potential benefit: If successful, the supplement could improve muscle mass and strength, reduce inflammation and oxidative stress, and help restore immune and mitochondrial function in malnourished older adults.
How similar studies have gone: Previous trials of protein/BCAA, omega‑3, and micronutrient supplementation in older adults have shown mixed but sometimes promising effects on muscle mass and function, while combinations targeting mitochondrial function remain less well tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥75 years * Patients entering a rehabilitation program * Diagnosis of malnutrition defined by a MNA-SF (mini-nutritional assessment short form) score below 11 points. * Commitment to accept the nutritional supplement proposed, willing and able to give written informed consent * Ability to understand and comply with the requirements of the study Exclusion Criteria: * Presence of malignancy, * Life expectancy of less than two months calculated by Multidimensional Prognostic Index (MPI ), * Congestive heart failure (NYHA IV), * Chronic renal disease (creatinine clearance \<40 ml/min calculated by cockroft), * Liver cirrhosis (Child B-C), * Tube/percutaneous endoscopic gastrostomy feeding or parenteral nutrition, * Severe dysphagia, * Mini-Mental State Examination (MMSE)≤18 and MNA\>11 points. MMSE ≥ 18 identifies patients with mild form of cognitive impairment; those patients generally do not have problems in swallowing and are able to take drugs. * Severe anaemia (Hb\<10 g/l) or leukopenia (\<2G/l).
Where it's running
-
Chuv
Lausanne, Switzerland, Switzerland Recruiting
Study contacts
- Principal investigator: Patrizia D'amelio — Service de gériatrie et réadaptation gériatrique-CHUV
- Study coordinator: Patrizia D'amelio
- Email: patrizia.damelio@chuv.ch
- Phone: +41213143712
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preoperative Immunonutrition for bone and soft tissue sarcoma patients
This study tests whether a short course of an oral nutrition supplement before surgery can help patients with bone or soft tissue sarcomas recover better after major tumor-related surgery.
-
Even protein distribution plus exercise for people awaiting liver transplant
This trial tests whether spreading daily protein evenly and combining it with a 12-week exercise program improves nutrition, muscle mass, and function in people waiting for a liver transplant compared with uneven protein timing or usual advice.
-
High-protein, plant-dominant diet for people with liver cirrhosis
This 6-month test compares a high-protein, mostly plant-based diet to a usual low-fat animal-protein diet in adults with decompensated cirrhosis who are awaiting kidney transplant to see which better preserves nutrition and muscle.
-
Cognitive effects of stomach or esophagus cancer surgery
This study will see how often people who have surgery for stomach or esophagus cancer develop postoperative delirium and whether it is linked to preoperative depression, frailty, malnutrition, sarcopenia, or lower quality of life.
-
How nutrition and body composition relate to outcomes in people with IBD
This study will see if nutrition and muscle mass affect outcomes in people with Crohn's disease or ulcerative colitis who are starting advanced medicines or having IBD-related surgery.
-
Assessing muscle mass and strength in patients with cirrhosis
This study is testing how muscle mass and strength change in people with cirrhosis to see how it affects their daily lives and health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.